Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia
Journal of InfectionPublished 30 March 2009
Emma R. Miller, Margaret Hellard, S. Bowden, Mandvi Bharadwaj, Campbell Aitken
Citations55
SJR quartileQ1
SJR score2.05
SNIP1.77
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Investigation of risk factors for hepatitis C virus, hepatitis B virus and HIV infection in injecting drug users in greater Melbourne at the time of their recruitment found ongoing engagement with young IDU is critical to address blood borne viral infections and other health and social harms associated with injecting drug use.
Abstract
Ongoing engagement with young IDU, through the provision of harm reduction education and resources, is critical if we are to address blood borne viral infections and other health and social harms associated with injecting drug use.
Keywords
Medicine
BMC Medical Research MethodologyAlternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio
4,138 Citations2003Aluísio J. D. Barros, Vânia Naomi Hirakata
Australian Infection ControlThe Australian Immunisation Handbook
908 Citations2000Andrea Bradford
Use of the vaccine combinations varies somewhat between states, with two options (Pathways) available for immunisation at 2, 4, 6 and 12 months of age.
American Journal of EpidemiologyBINOMIAL REGRESSION IN GLIM: ESTIMATING RISK RATIOS AND RISK DIFFERENCES1
626 Citations1986Sholom Wacholder
Macros for use with the program GLIM provide a simple method to compute parameters other than the odds ratio while adjusting for confounding factors.
Journal of HepatologyCharacteristics of patients with dual infection by hepatitis B and C viruses
371 Citations1998Jean‐Pierre Zarski, Benoit Bohn +8 more
It is suggested that HBV DNA replication inhibits HCV RNA replication in patients with chronic active hepatitis B and C but increases the severity of histological lesions.
AddictionIncidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia
236 Citations2006Lisa Maher, Bin Jalaludin +5 more
Women, new initiates and IDUs recruited via outreach appear to be at increased risk of infection and the first evidence outside North America of the link between shared use of drug preparation equipment and incident HCV infection is provided.
Australian and New Zealand Journal of Public HealthEstimates of chronic hepatitis B virus infection in Australia, 2000
130 Citations2004Belinda O’Sullivan, Heather F. Gidding +4 more
The prevalence of chronic hepatitis B virus infection in Australia and attributable proportions associated with specific demographic groups at higher risk of infection are estimated to be about 1 in 10,000.
International Journal of Medical SciencesHepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Dual Infection
122 Citations2006Zhihua Liu, Jinlin Hou
Patients with dual HBV and HCV infection have more severe liver disease, and are at an increased risk for progression to hepatocellular carcinoma (HCC), and treatment of viral hepatitis due to dualHBV/HCV infection represents a challenge.
Journal of Medical VirologyRole of beauty treatment in the spread of parenterally transmitted hepatitis viruses in Italy
105 Citations2004Andrea Mariano, Alfonso Mele +10 more
It is concluded that certain beauty treatments play an important role in the spread of HBV and HCV infections in Italy.
Epidemiology and InfectionThe prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities
104 Citations2004Margaret Hellard, Jane S. Hocking +1 more
The results show prisoners who injected drugs outside of prison continue to inject in prison but in a less safe manner.
Journal of InfectionPrevalence of Hepatitis C Virus Infection Among Injecting Drug Users in Glasgow 1990–1996: are Current Harm Reduction Strategies Working?
102 Citations2000A. Taylor, David Goldberg +7 more
The prevalence of HCV among injectors in Glasgow has decreased during the era of needle/syringe exchange, however, there is evidence to suggest that the incidence of infection remains high.
European Addiction ResearchDrugs and Social Exclusion in Ten European Cities
99 Citations2005Joan Carles March, Eugenia Oviedo‐Joekes +1 more
Personal, social, and economic conditions are all linked in a process of social exclusion that compounds problem drug misuse and there is a clear need for specific programs targeting specific groups, i.e., distinct strategies must be set in place.
Journal of Gastroenterology and HepatologyRisk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south‐western Sydney, Australia
97 Citations2004Lisa Maher, Kerry Chant +2 more
The prevalence of HCV and hepatitis B virus infection and associated risk behaviors among injecting drug users (IDUs) screened in south‐western Sydney as part of a multisite prospective cohort study were determined.
The Medical Journal of AustraliaAcute hepatitis C virus infection in an Australian prison inmate: tattooing as a possible transmission route
63 Citations2001Jeffrey J. Post, Andrew R. Lloyd +4 more
Introducing licensed tattooists, and thereby improving infection control practices, may reduce the risk of hepatitis C virus infection in prisons.
Drugs Education Prevention and PolicyThe War on Drugs a war on drug users?
56 Citations2000L. Buchanan
The Journal of Infectious DiseasesMolecular Epidemiology of Hepatitis C Virus in a Social Network of Injection Drug Users
54 Citations2004Campbell Aitken, Rhonda McCaw +7 more
International Journal of Infectious DiseasesHepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors
41 Citations2008Emma R. Miller, Peng Bi +1 more
Entry HCV seroprevalence in South Australian prisoners is extremely high and may have contributed to a 'ceiling effect', minimizing the observable seroconversion rate.
Journal of Public HealthScreening for HIV, HBV, and HCV markers among drug users in treatment in rural south-east England
29 Citations2000J. Edeh, Paul Spalding
The prevalence of HIV, HBV and HCV in the rural population is as high as has been reported for inner cities and the poor uptake of hepatitis B vaccination among drug users, their poor response to HIV antibody test and poor health service utilization suggest the need for an urgent appraisal of service provision and a review of prevention and treatment strategies.
Journal of Medical VirologyChange in hepatitis C virus genotype in injecting drug users
24 Citations2004Campbell Aitken, Rhonda McCaw +6 more
Venous blood samples obtained from Vietnamese‐Australian injecting drug users who participated in successive studies conducted in Melbourne, Australia, were genotyped using the Bayer line probe assay and genotype confirmed by sequencing whenever possible, implying that HCV genotype change in injected drug users occurs at least as frequently as infections in naïve individuals.
Australian and New Zealand Journal of Public HealthThe prevalence and risk behaviours associated with the transmission of blood‐borne viruses among ethnic‐Vietnamese injecting drug users
22 Citations2006Margaret Hellard, Oanh Kieu Nguyen +4 more
The objective was to measure the prevalence and determinants of blood‐borne virus transmission in ethnic Vietnamese injecting drug users (IDUs) and to investigate the relationship between injection drug use and BBV transmission.